Volume 6, Number 1 (Vol.6 No.1 Oct 2017)                   rbmb.net 2017, 6(1): 74-79 | Back to browse issues page


XML Print


MD Gastroenterology and Hepatology Research Center, Institute of Basic and Clinical Physiology sciences, kerman University of Medical Sciences, Kerman, Iran
Abstract:   (1260 Views)
 

Background: Several components of metabolic syndrome (MetS) facilitate its diagnosis, including abdominal obesity, hyperlipidemia, high blood pressure, and insulin resistance. The production of tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6) seem to be associated with MetS components. The aim of this study was to evaluate the correlation between  the serum levels of TNFα and IL-6  with metabolic syndrome and its components.

Methods: This case-control study investigated a total of 250 subjects, comprising 125 healthy controls from the Kerman Blood Transfusion Organization and 125 metabolic syndrome patients. Serum IL-6 and TNF-a levels were measured using the ELISA technique.

Results: There was a significant increase in the serum levels of TNF-a and IL-6 in patients with metabolic syndrome compared with the controls. However, a lack of correlation between MetS components and TNF-a and IL-6 serum levels was detected.

Conclusions: Patients with MetS had significantly raised serum IL-6 and TNF-a levels compared with the controls, supporting the evidence that inflammation plays an important role in the immunopathogenesis of the disease. Additionally, serum levels of IL-6 and TNF-a are suggested as valuable predicting factors for MetS. The lack of association between IL-6 and TNF-a serum levels and MetS components remains to be investigated by further research.

Full-Text [PDF 475 kb]   (408 Downloads)    
Type of Article: Original Article | Subject: Immunology
Received: 2016/11/19 | Accepted: 2017/01/17 | Published: 2017/04/20